The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2025 | Understanding treatment approaches for older patients with metastatic pancreatic cancer
Efrat Dotan, MD, Fox Chase Cancer Center, Philadelphia, PA, highlights the unique challenges metastatic pancreatic cancer present for older patients, who face additional burdens from comorbidities, functional decline, cognitive impairment, and limited social support. These vulnerabilities need to be addressed at baseline before starting chemotherapy, potentially reducing adverse effects and improving treatment tolerance. Applying these principles to gastrointestinal cancers could significantly enhance patient management and overall survival. This interview took place at the ASCO GI Cancers Symposium 2025 in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
